PKCα-Specific Phosphorylation of the Troponin Complex in Human Myocardium: A Functional and Proteomics Analysis
Author(s) -
Viola Kooij,
Pingbo Zhang,
Sander R. Piersma,
Vasco Sequeira,
Nicky M. Boontje,
Paul J.M. Wijnker,
Connie R. Jiménez,
Kornélia Jaquet,
Cristobal G. dos Remedios,
Anne M. Murphy,
Jennifer E. Van Eyk,
Jolanda van der Velden,
Ger J.M. Stienen
Publication year - 2013
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0074847
Subject(s) - protein kinase c , phosphorylation , troponin i , troponin complex , myofilament , troponin , chemistry , medicine , troponin t , microbiology and biotechnology , biology , biochemistry , myocyte , myocardial infarction
Aims Protein kinase Cα (PKCα) is one of the predominant PKC isoforms that phosphorylate cardiac troponin. PKCα is implicated in heart failure and serves as a potential therapeutic target, however, the exact consequences for contractile function in human myocardium are unclear. This study aimed to investigate the effects of PKCα phosphorylation of cardiac troponin (cTn) on myofilament function in human failing cardiomyocytes and to resolve the potential targets involved. Methods and Results Endogenous cTn from permeabilized cardiomyocytes from patients with end-stage idiopathic dilated cardiomyopathy was exchanged (∼69%) with PKCα-treated recombinant human cTn (cTn (DD+PKCα)). This complex has Ser23/24 on cTnI mutated into aspartic acids (D) to rule out in vitro cross-phosphorylation of the PKA sites by PKCα. Isometric force was measured at various [Ca 2+ ] after exchange. The maximal force (F max ) in the cTn (DD+PKCα) group (17.1±1.9 kN/m 2 ) was significantly reduced compared to the cTn (DD) group (26.1±1.9 kN/m 2 ). Exchange of endogenous cTn with cTn (DD+PKCα) increased Ca 2+ -sensitivity of force (pCa 50 = 5.59±0.02) compared to cTn (DD) (pCa 50 = 5.51±0.02). In contrast, subsequent PKCα treatment of the cells exchanged with cTn (DD+PKCα) reduced pCa 50 to 5.45±0.02. Two PKCα-phosphorylated residues were identified with mass spectrometry: Ser198 on cTnI and Ser179 on cTnT, although phosphorylation of Ser198 is very low. Using mass spectrometry based-multiple reaction monitoring, the extent of phosphorylation of the cTnI sites was quantified before and after treatment with PKCα and showed the highest phosphorylation increase on Thr143. Conclusion PKCα-mediated phosphorylation of the cTn complex decreases F max and increases myofilament Ca 2+ -sensitivity, while subsequent treatment with PKCα in situ decreased myofilament Ca 2+ -sensitivity. The known PKC sites as well as two sites which have not been previously linked to PKCα are phosphorylated in human cTn complex treated with PKCα with a high degree of specificity for Thr143.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom